We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




A Potential Point-of-Care Method for the Diagnosis of Sepsis

By LabMedica International staff writers
Posted on 21 Nov 2019
Print article
Image: Three-dimensional rendering of various types of white blood cells (Photo courtesy of Wikimedia Commons)
Image: Three-dimensional rendering of various types of white blood cells (Photo courtesy of Wikimedia Commons)
As part of the effort to create better methods to detect and treat sepsis, researchers developed a technique that enables measurement of the activation and function of white blood cells.

Sepsis is caused by an inflammatory immune response triggered by an infection. It is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. Common signs and symptoms include fever, increased heart rate, increased breathing rate, and confusion. There may also be symptoms related to a specific infection, such as a cough with pneumonia, or painful urination with a kidney infection. In the very young, old, and people with a weakened immune system, there may be no symptoms of a specific infection and the body temperature may be low or normal, rather than high.

Current testing and diagnostic approaches fail to provide the precise and timely information needed to treat sepsis. To correct this, investigators at Brigham and Women's Hospital (Boston, MA, USA) designed a new method, based on microfluidics, which relies on minute channels to separate 50 microliter samples of peripheral blood into fractions comprising either the larger white blood cells or the smaller red blood cells and other elements of the blood.

The size-based microfluidic method was combined with novel isodielectric separation technology - developed by colleagues at the Massachusetts Institute of Technology (Cambridge, MA) - which measured cellular electrical activity. This method detected changes that occurred when white blood cells became activated and could distinguish patients with and without inflammation, such as in sepsis.

The investigators used the system to assess leukocyte phenotype and function over a period of seven days in serial samples from 18 hospitalized patients with sepsis and 10 healthy subjects.

Results revealed that the sepsis samples had significantly higher levels of CD16dim and CD16− neutrophils and CD16+ “intermediate” monocytes, as well as significantly lower levels of neutrophil-elastase release, O2 production, and phagolysosome formation. Repeated sampling of sepsis patients over seven days showed that leukocyte activation (measured by isodielectric separation) and leukocyte phenotype and function were significantly more predictive of the clinical course than complete-blood-count parameters.

"Our idea was to develop a point-of-care diagnostic test that, instead of focusing on the white blood cell count, would inform us about white blood cell activation state and function," said senior author Dr. Bruce Levy, chief of the division of pulmonary and critical care medicine at Brigham and Women's Hospital. "It has been exciting for us, as translational scientists, to work on a solution with outstanding bioengineer colleagues. Together, we are able to address a truly important clinical problem."

The potential use of the leukocyte function test to diagnose sepsis was described in the November 11, 2019, online edition of the journal Nature Biomedical Engineering.

Related Links:
Brigham and Women's Hospital
Massachusetts Institute of Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.